{{DISPLAYTITLE:Technetium (<sup>99m</sup>Tc) tilmanocept}}
{{Infobox drug
| drug_name         = Technetium (<sup>99m</sup>Tc) tilmanocept
| IUPAC_name        = Dextran <nowiki>3-[(2-aminoethyl)thio]propyl 17-carboxy-10,13,16-tris(carboxymethyl)-8-oxo-4-thia-7,10,13,16-tetraazaheptadec-1-yl 3-[[2-[[</nowiki>1-imino-2-(<small>D</small>-mannopyranosylthio)ethyl]amino]ethyl]thio]propyl ether technetium-99m complexes
| image             = Technetium-99m tilmanocept.svg
| width             = 400px
| alt               = 
| caption           =

<!-- Clinical data -->
| tradename         = Lymphoseek
| Drugs.com         = {{Drugs.com|parent|lymphoseek}}
| MedlinePlus       = 
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      = C
| pregnancy_category= 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = Rx-only
| legal_status      = 
| routes_of_administration = [[Intradermal]], [[Subcutaneous injection|subcutaneous]]

<!-- Pharmacokinetic data -->
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 1.75 to 3.05 hours at injection site
| excretion         =

<!-- Identifiers -->
| CAS_number        = 
| ATCvet            = 
| ATC_prefix        = V09
| ATC_suffix        = IA09
| PubChem           = 
| DrugBank          =

<!-- Chemical data -->
| chemical_formula  = (C<sub>6</sub>H<sub>10</sub>O<sub>5</sub>)<sub>n</sub>(C<sub>19</sub>H<sub>28</sub>N<sub>4</sub>O<sub>9</sub>S<sup>99m</sup>Tc)<sub>3–8</sub>(C<sub>13</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub>)<sub>12–20</sub>(C<sub>5</sub>H<sub>11</sub>NS)<sub>0–17</sub>
| molecular_weight  = 15,281–23,454 g/mol<ref name="FDA-Druginfo">{{Drugs.com|pro|lymphoseek}}</ref>
}}
'''Technetium (<sup>99m</sup>Tc) tilmanocept''', trade name '''Lymphoseek''', is a [[radiopharmaceutical]] diagnostic imaging agent approved by the U.S. [[Food and Drug Administration]] (FDA) for the imaging of [[lymph node]]s.<ref name="FDA-Druginfo" /><ref>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm343525.htm</ref> It is used to locate those lymph nodes which may be draining from [[tumor]]s, and assist doctors in locating those lymph nodes for removal during [[surgery]].<ref>{{Cite journal 
| last1 = Marcinow | first1 = A. M. 
| last2 = Hall | first2 = N. 
| last3 = Byrum | first3 = E. 
| last4 = Teknos | first4 = T. N. 
| last5 = Old | first5 = M. O. 
| last6 = Agrawal | first6 = A. 
| title = Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: Initial institutional report in an ongoing phase 3 study 
| journal = JAMA otolaryngology-- head & neck surgery 
| volume = 139 
| issue = 9 
| pages = 895–902 
| year = 2013 
| doi = 10.1001/jamaoto.2013.4239 
| pmid = 24051744 
| pmc = 4301415
}}</ref>

==References==
{{Reflist}}

{{Radiopharmaceuticals}}

[[Category:Radiopharmaceuticals]]
[[Category:Technetium-99m]]


{{pharma-stub}}
{{med-diagnostic-stub}}